Randomized Controlled Trial of Ethyl-Eicosapentaenoic Acid in Huntington Disease: The TREND-HD Study

Overview of attention for article published in Archives of neurology (1960. Online), December 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

blogs: 1 blog
patent: 143 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 127 Mendeley

So far, Altmetric has seen 143 patents that reference this research output.

Use of pridopidine for treating dystonias

Grant US-12564582-B2

United States of America

03 Mar 2026

Methods of reducing the risk of cardiovascular events in a subject with atrial…

Grant US-12427134-B2

United States of America

30 Sep 2025

Pridopidine for treating Huntington's disease

Grant US-12390456-B2

United States of America

19 Aug 2025

Methods of reducing the risk of cardiovascular events in a subject

Grant US-12246003-B2

United States of America

11 Mar 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 139 additional patents.